← Evidence map

ArticleAlimentary pharmacology & therapeutics2022

Editorial: does TAF have a better or worse safety profile than TDF, to treat hepatitis B?

Andrew HillPubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35362127